Biomaterials approaches in vascular engineering: A review of past and future trends

Biomaterials for Tissue Engineering Applications: A Review of the Past and Future Trends

Volumn , Issue , 2011, Pages 457-487

  Hanjaya Putra, Donny ^a   Wanjare, Maureen ^a   Gerecht, Sharon ^a  

^a Johns Hopkins University   (United States)

Author keywords

Endothelial cells (ECs); Extracellular matrix (ECM); Hydrogels; Smooth muscle cells (SMCs); Vascular morphogenesis

Indexed keywords

EID: 84869846476     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-0385-2_16     Document Type: Chapter

References (153)

1. Rouwkema, J., N. C. Rivron, and C. A. van Blitterswijk, Vascularization in tissue engineering. Trends in Biotechnology, 2008. 26(8): p. 434-441.
2. Laschke, M. W., et al., Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Engineering, 2006. 12(8): p. 2093-2104.
3. Levenberg, S., et al., Engineering vascularized skeletal muscle tissue. Nature Biotechnology, 2005. 23(7): p. 879-884.
4. Dvir, T., et al., Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proceedings of the National Academy of Sciences of the United States of America, 2009. 106(35): p. 14990-14995.
5. Caspi, O., et al., Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circulation Research, 2007. 100(2): p. 263-272.
6. Lesman, A., et al., Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Engineering Part A, 2010. 16(1): p. 115-125.
7. Hungerford, J. E., et al., Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Developmental Biology, 1996. 178(2): p. 375-392.
8. Drake, C. J., J. E. Hungerford, and C. D. Little, Morphogenesis of the first blood vessels. Annals of the New York Academy of Sciences, 1998. 857: p. 155-179, Morphogenesis: cellular interactions.
9. Gerecht-Nir, S. and J. Itskovitz-Eldor, The promise of human embryonic stem cells. Best Practice & Research. Clinical Obstetrics & Gynaecology, 2004. 18(6): p. 843-852.
10. Patan, S., Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. Journal of Neuro-Oncology, 2000. 50(1): p. 1-15.
11. Ribatti, D., Hemangioblast does exist. Leukemia Research, 2008. 32(6): p. 850-854.
12. Yamashita, J., Differentiation and diversification of vascular cells from embryonic stem cells. International Journal of Hematology, 2004. 80(1): p. 1-6.
13. Yamashita, J., et al., Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature, 2000. 408(6808): p. 92-96.
14. Bai, H. and Z. Z. Wang, Directing human embryonic stem cells to generate vascular progenitor cells. Gene Therapy, 2007. 15(2): p. 89-95.
15. Vo, E., et al., Smooth-muscle-like cells derived from human embryonic stem cells support and augment cord-like structures in vitro. Stem Cell Reviews and Reports, 2010. 6(2): p. 237-247.
16. Yu, J., et al., Induced pluripotent stem cell lines derived from human somatic cells. Science, 2007. 318(5858): p. 1917-1920.
17. Takahashi, K., et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007. 131(5): p. 861-872.
18. Pittenger, M., et al., Multilineage potential of adult human mesenchymal stem cells. Science, 1999. 284(5411): p. 143-147.
19. Liu, D., X. Li, and Z. Zhang, Differentiation of human bone marrow mesenchymal stem cells into vascular endothelium-like cells induced by vascular endothelial growth factor and basic fibroblast growth factor in vitro. Journal of Clinical Rehabilitative Tissue Engineering Research, 2008. 12(47): p. 9216-9220.
20. Gong, Z. and L. E. Niklason, Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). The FASEB Journal, 2008. 22(6): p. 1635-1648.
21. Miranville, A., et al., Improvement of postnatal neovascularization by human adipose tissuederived stem cells. Circulation, 2004. 110(3): p. 349-355.
22. Traktuev, D. O., et al., A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circulation Research, 2008. 102(1): p. 77-85.
23. Asahara, T., et al., Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997. 275(5302): p. 964-966.
24. Au, P., et al., Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood, 2008. 111(3): p. 1302-1305
25. Cherqui, S., et al., Isolation and angiogenesis by endothelial progenitors in the fetal liver. Stem Cells, 2006. 24(1): p. 44-54.
26. Grenier, G., et al., Resident endothelial precursors in muscle, adipose, and dermis contribute to postnatal vasculogenesis. Stem Cells, 2007. 25(12): p. 3101-3110.
27. Zengin, E., et al., Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development, 2006. 133(8): p. 1543-1551.
28. Mead, L. E., et al., Isolation and characterization of endothelial progenitor cells from human blood. Current Protocols in Stem Cell Biology, 2008. Chapter 2.
29. Yoder, M. C., et al., Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood, 2007. 109(5): p. 1801-1809.
30. Wu, X., et al., Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. American Journal of Physiology. Heart and Circulatory Physiology, 2004. 287(2): p. H480-H487.
31. Jie, L., Z. Yan-Ping, and S. K. Robert, Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microscopy Research and Technique, 2003. 60(1): p. 107-114.
32. Smith, M. K., et al., Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Engineering, 2004. 10 (1-2): p. 63-71.
33. Nomi, M., et al., Principals of neovascularization for tissue engineering. Molecular Aspects of Medicine, 2002. 23(6): p. 463-483.
34. Richardson, T. P., et al., Polymeric system for dual growth factor delivery. Nature Biotechnology, 2001. 19(11): p. 1029-1034.
35. Lee, J., M. J. Cuddihy, and N. A. Kotov, Three-dimensional cell culture matrices: state of the art. Tissue Engineering Part B: Reviews, 2008. 14(1): p. 61-86.
36. Eble, J. A. and S. Niland, The extracellular matrix of blood vessels. Current Pharmaceutical Design, 2009. 15: p. 1385-1400.
37. Lutolf, M. P. and J. A. Hubbell, Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nature Biotechnology, 2005. 23(1): p. 47-55.
38. Toole, B. P., Hyaluronan: from extracellular glue to pericellular cue. Nature Reviews. Cancer, 2004. 4(7): p. 528-539.
39. Wijelath, E. S., et al., Heparin-II domain of fibronectin is a vascular endothelial growth factorbinding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circulation Research, 2006. 99(8): p. 853-860.
40. Francis, S. E., et al., Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arteriosclerosis, Thrombosis, and Vascular Biology, 2002. 22(6): p. 927-933.
41. Astrof, S., D. Crowley, and R. O. Hynes, Multiple cardiovascular defects caused by the absence of alternatively spliced segments of fibronectin. Developmental Biology, 2007. 311(1): p. 11-24.
42. Davis, G. E. and D. R. Senger, Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression. Current Opinion in Hematology, 2008. 15(3): p. 197-203.
43. Robins, S. P., Biochemistry and functional significance of collagen cross-linking. Biochemical Society Transactions, 2007. 35(5): p. 849-852.
44. Place, E. S., N. D. Evans, and M. M. Stevens, Complexity in biomaterials for tissue engineering. Nature Materials, 2009. 8(6): p. 457-470.
45. Sun, G., et al., Functional groups affect physical and biological properties of dextranbased hydrogels. Journal of Biomedical Materials Research Part A, 2010. 93(3): p. 1080-1090
46. Keselowsky, B. G., D. M. Collard, and A. J. GarcÃa, Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proceedings of the National Academy of Sciences of the United States of America, 2005. 102(17): p. 5953-5957.
47. Ehrbar, M., et al., Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circulation Research, 2004. 94(8): p. 1124-1132.
48. Ehrbar, M., et al., Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. Journal of Controlled Release, 2005. 101 (1-3): p. 93-109.
49. Davis, G. E., W. Kon, and A. N. Stratman, Mechanisms controlling human endothelial lumen formation and tube assembly in three-dimensional extracellular matrices. Birth Defects Research. Part C, Embryo Today: Reviews, 2007. 81(4): p. 270-285.
50. Zhou, X., et al., Fibronectin fibrillogenesis regulates three-dimensional neovessel formation. Genes & Development, 2008. 22(9): p. 1231-1243.
51. Janmey, P. A., J. P. Winer, and J. W. Weisel, Fibrin gels and their clinical and bioengineering applications. Journal of the Royal Society Interface, 2009. 6(30): p. 1-10.
52. Bayless, K. J. and G. E. Davis, The Cdc42 and Rac1 GTPases are required for capillary lumen formation in three-dimensional extracellular matrices. Journal of Cell Science, 2002. 115(6): p. 1123-1136.
53. Kamei, M., et al., Endothelial tubes assemble from intracellular vacuoles in vivo. Nature, 2006. 442(7101): p. 453-456.
54. Ingber, D. E. and J. Folkman, Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. The Journal of Cell Biology, 1989. 109(1): p. 317-330.
55. Folkman, J., C. C. Haudenschild, and B. R. Zetter, Long-term culture of capillary endothelial cells. Proceedings of the National Academy of Sciences of the United States of America, 1979. 76(10): p. 5217-5221.
56. Davis, G. E. and C. W. Camarillo, Regulation of endothelial cell morphogenesis by integrins, mechanical forces, and matrix guidance pathways. Experimental Cell Research, 1995. 216(1): p. 113-123.
57. Rundhaug, J. E., Matrix metalloproteinases and angiogenesis. Journal of Cellular and Molecular Medicine, 2005. 9(2): p. 267-285.
58. Van Hinsbergh, V. W. M., M. A. Engelse, and P. H. A. Quax, Pericellular proteases in angiogenesis and vasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 2006. 26(4): p. 716-728.
59. Urbich, C. and S. Dimmeler, Endothelial progenitor cells: characterization and role in vascular biology. Circulation Research, 2004. 95(4): p. 343-353.
60. Stratman, A. N., et al., Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices. Blood, 2009. 114(2): p. 237-247.
61. Chun, T. H., et al., MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. The Journal of Cell Biology, 2004. 167(4): p. 757-767.
62. Collen, A., et al., Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrincollagen matrix. Blood, 2003. 101(5): p. 1810-1817.
63. Hanjaya-Putra, D., et al., Vascular endothelial growth factor and substrate mechanics regulate in vitro tubulogenesis of endothelial progenitor cells. Journal of Cellular and Molecular Medicine, 2009. DOI: 10.1111/j.1582-4934.2009.00981.x
64. Sage, E. H. and R. B. Vernon, Regulation of angiogenesis by extracellular matrix: the growth and the glue. Journal of Hypertension, 1994. 12(10): p. S145-S152.
65. Sieminski, A. L., et al., The stiffness of three-dimensional ionic self-assembling peptide gels affects the extent of capillary-like network formation. Cell Biochemistry and Biophysics, 2007. 49(2): p. 73-83.
66. Lutolf, M. P., et al., Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proceedings of the National Academy of Sciences of the United States of America, 2003. 100(9): p. 5413-5418.
67. Zisch, A. H., et al., Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. The FASEB Journal, 2003. 17(15): p. 2260-2262.
68. Seliktar, D., et al., MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing. Journal of Biomedical Materials Research. Part A, 2004. 68(4): p. 704-716.
69. Zisch, A. H., M. P. Lutolf, and J. A. Hubbell, Biopolymeric delivery matrices for angiogenic growth factors. Cardiovascular Pathology, 2003. 12(6): p. 295-310.
70. Ferrara, N., H. P. Gerber, and J. LeCouter, The biology of VEGF and its receptors. Natural Medicines, 2003. 9(6): p. 669-676.
71. Fischbach, C. and D. J. Mooney, Polymers for pro-and anti-angiogenic therapy. Biomaterials, 2007. 28(12): p. 2069-2076.
72. Von Degenfeld, G., et al., Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. The FASEB Journal, 2006. 20(14): p. 2657-2659.
73. Silva, E. A. and D. J. Mooney, Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials. 2010. 31(6): p. 1235-1241.
74. Hao, X., et al., Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovascular Research, 2007. 75(1): p. 178-185.
75. Chiu, L. L. Y. and M. Radisic, Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials, 2010. 31(2): p. 226-241.
76. Semenza, G. L., HIF-1 and human disease: one highly involved factor. Genes & Development, 2000. 14(16): p. 1983-1991.
77. Bosch-Marce, M., et al., Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circulation Research, 2007. 101(12): p. 1310-1318.
78. Lee, K., et al., Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumorinduced mobilization of circulating angiogenic cells. Proceedings of the National Academy of Sciences of the United States of America, 2009. 106(7): p. 2353-2358.
79. Lee, K., et al., Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proceedings of the National Academy of Sciences of the United States of America, 2009. 106(42): p. 17910-17915.
80. Abaci, H. E., et al., Adaptation to oxygen deprivation in cultures of human pluripotent stem cells, endothelial progenitor cells, and umbilical vein endothelial cells. American Journal of Physiology. Cell Physiology, 2010. 298(6): p. C1527-C1537.
81. Hirschi, K. K. and P. A. D'Amore, Pericytes in the microvasculature. Cardiovascular Research, 1996. 32(4): p. 687-698.
82. Hirschi, K. K., S. A. Rohovsky, and P. A. D'Amore, PDGF, TGF-Î2, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. The Journal of Cell Biology, 1998. 141(3): p. 805-814.
83. Hirschi, K. K. and M. W. Majesky, Smooth muscle stem cells. Anatomical Record. Part A Discoveries in Molecular, Cellular, and Evolutionary Biology, 2004. 276(1): p. 22-33.
84. Davis, G. E. and W. B. Saunders, Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. The Journal of Investigative Dermatology. Symposium Proceedings, 2006. 11(1): p. 44-56.
85. Saunders, W. B., et al., Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. The Journal of Cell Biology, 2006. 175(1): p. 179-191.
86. et al., Tissue engineering: creation of long-lasting blood vessels. Nature, 2004. 428(6979): p. 138-139.
87. Au, P., et al., Bone marrow derived mesenchymal stem cells facilitate engineering of longlasting functional vasculature. Blood, 2008. 111(9): p. 4551-4558.
88. Soucy, P. A. and L. H. Romer, Endothelial cell adhesion, signaling, and morphogenesis in fibroblast-derived matrix. Matrix Biology, 2009. 28(5): p. 273-283.
89. Sorrell, J. M., M. A. Baber, and A. I. Caplan, A self-assembled fibroblast-endothelial cell coculture system that supports in vitro vasculogenesis by both human umbilical vein endothelial cells and human dermal microvascular endothelial cells. Cells, Tissues, Organs, 2007. 186(3): p. 157-168.
90. Sottile, J. and D. C. Hocking, Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Molecular Biology of the Cell, 2002. 13(10): p. 3546-3559.
91. Romer, L. H., K. G. Birukov, and J. G. Garcia, Focal adhesions: paradigm for a signaling nexus. Circulation Research, 2006. 98(5): p. 606-616.
92. Bettinger, C. J., Z. Zhang, S. Gerecht, J. Borenstein, and R. Langer, Enhancement of in vitro capillary tube formation by substrate nanotopography. Advanced Materials, 2008. 20: p. 99-103.
93. Gafni, Y., et al., Design of a filamentous polymeric scaffold for in vivo guided angiogenesis. Tissue Engineering, 2006. 12(11): p. 3021-3034.
94. Igarashi, S., J. Tanaka, and H. Kobayashi, Micro-patterned nanofibrous biomaterials. Journal of Nanoscience and Nanotechnology, 2007. 7(3): p. 814-817.
95. Ingber, D. E., Mechanical signaling and the cellular response to extracellular matrix in angiogenesis and cardiovascular physiology. Circulation Research, 2002. 91(10): p. 877-887.
96. Kilarski, W. W., et al., Biomechanical regulation of blood vessel growth during tissue vascularization. Nature Medicine, 2009. 15(6): p. 657-664.
97. Mammoto, A., et al., A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature, 2009. 457(7233): p. 1103-1108.
98. Sieminski, A. L., R. P. Hebbel, and K. J. Gooch, The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Experimental Cell Research, 2004. 297(2): p. 574-584.
99. Deroanne, C. F., C. M. Lapiere, and B. V. Nusgens, In vitro tubulogenesis of endothelial cells by relaxation of the coupling extracellular matrix-cytoskeleton. Cardiovascular Research, 2001. 49(3): p. 647-658.
100. Stephanou, A., et al., The rigidity in fibrin gels as a contributing factor to the dynamics of in vitro vascular cord formation. Microvascular Research, 2007. 73(3): p. 182-190.
101. Kniazeva, E. and A. J. Putnam, Endothelial cell traction and ECM density influence both capillary morphogenesis and maintenance in 3-D. American Journal of Physiology. Cell Physiology, 2009. 297(1): p. C179-C187.
102. Singer, A. J. and R. A. F. Clark, Cutaneous wound healing. The New England Journal of Medicine, 1999. 341(10): p. 738-746.
103. Eiselt, P., et al., Porous carriers for biomedical applications based on alginate hydrogels. Biomaterials, 2000. 21(19): p. 1921-1927.
104. Lim, F. and A. M. Sun, Microencapsulated islets as bioartificial endocrine pancreas. Science, 1980. 210(4472): p. 908-910.
105. Figliuzzi, M., et al., Biocompatibility and function of microencapsulated pancreatic islets. Acta Biomaterialia, 2006. 2(2): p. 221-227.
106. Dean, S. K., et al., Differentiation of encapsulated embryonic stem cells after transplantation. Transplantation, 2006. 82(9): p. 1175-1184.
107. Gerecht-Nir, S., et al., Three-dimensional porous alginate scaffolds provide a conducive environment for generation of well-vascularized embryoid bodies from human embryonic stem cells. Biotechnology and Bioengineering, 2004. 88(3): p. 313-320.
108. Perets, A., et al., Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. Journal of Biomedical Materials Research. Part A, 2003. 65(4): p. 489-497.
109. Almond, A., Hyaluronan. Cellular and Molecular Life Sciences, 2007. 64(13): p. 1591-1596.
110. Dickinson, L. E., et al., Functional surfaces for high-resolution analysis of cancer cell interactions on exogenous hyaluronic acid. Biomaterials, 2010. 31(20): p. 5472-5478.
111. Liu, D., et al., Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proceedings of the National Academy of Sciences of the United States of America, 1996. 93(15): p. 7832-7837.
112. Toole, B. P., T. N. Wight, and M. I. Tammi, Hyaluronan-cell interactions in cancer and vascular disease. The Journal of Biological Chemistry, 2002. 277(7): p. 4593-4596.
113. Burdick, J. A., et al., Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules, 2004. 6(1): p. 386-391.
114. Gerecht, S., et al., Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 2007. 104(27): p. 11298-11303.
115. Stephen, P. M. and S. John, Immobilized RGD peptides on surface-grafted dextran promote biospecific cell attachment. Journal of Biomedical Materials Research, 2001. 56(3): p. 390-399.
116. Lévesque, S. G., R. M. Lim, and M. S. Shoichet, Macroporous interconnected dextran scaffolds of controlled porosity for tissue-engineering applications. Biomaterials, 2005. 26(35): p. 7436-7446.
117. Ferreira, L., M. H. Gil, and J. S. Dordick, Enzymatic synthesis of dextran-containing hydrogels. Biomaterials, 2002. 23(19): p. 3957-3967.
118. Ferreira, L. S., et al., Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials, 2007. 28(17): p. 2706-2717.
119. 2 is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis, 2001. 4(1): p. 11-20.
120. Jain, R. K., Molecular regulation of vessel maturation. Nature Medicine, 2003. 9(6): p. 685-693.
121. Dery, M. A., M. D. Michaud, and D. E. Richard, Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. The International Journal of Biochemistry & Cell Biology, 2005. 37(3): p. 535-540.
122. Pola, R., et al., The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nature Medicine, 2001. 7(6): p. 706-711.
123. Deckers, M. M., et al., Bone morphogenetic proteins stimulate angiogenesis through osteoblastderived vascular endothelial growth factor A. Endocrinology, 2002. 143(4): p. 1545-1553.
124. Trentin, D., et al., Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxiainducible factor-1alpha variant for local induction of angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 2006. 103(8): p. 2506-2511.
125. Zhang, Q.-X., et al., Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. The Journal of Surgical Research, 1997. 67(2): p. 147-154.
126. Suh, S., et al., Use of omentum as an in vivo cell culture system in tissue engineering. ASAIO Journal, 2004. 50(5): p. 464-467.
127. Lokmic, Z., et al., An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. The FASEB Journal, 2007. 21(2): p. 511-522.
128. Mian, R., et al., Formation of new tissue from an arteriovenous loop in the absence of added extracellular matrix. Tissue Engineering, 2000. 6(6): p. 595-603.
129. Cassell, O. C., et al., The influence of extracellular matrix on the generation of vascularized, engineered, transplantable tissue. Annals of the New York Academy of Sciences, 2001. 944: p. 429-442.
130. Manasseri, B., et al., Microsurgical arterovenous loops and biological templates: a novel in vivo chamber for tissue engineering. Microsurgery, 2007. 27(7): p. 623-629.
131. Morritt, A. N., et al., Cardiac tissue engineering in an in vivo vascularized chamber. Circulation, 2007. 115(3): p. 353-360.
132. Kneser, U., et al., Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Engineering, 2006. 12(7): p. 1721-1731.
133. Bach, A. D., et al., A new approach to tissue engineering of vascularized skeletal muscle. Journal of Cellular and Molecular Medicine, 2006. 10(3): p. 716-726.
134. Black, A. F., et al., In vitro reconstruction of a human capillary-like network in a tissueengineered skin equivalent. The FASEB Journal, 1998. 12(13): p. 1331-1340.
135. Tremblay, P. L., et al., In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue. The Journal of Pharmacology and Experimental Therapeutics, 2005. 315(2): p. 510-516.
136. Melero-Martin, J. M., et al., Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circulation Research, 2008. 103(2): p. 194-202.
137. Bettinger, C. J., et al., Microfabrication of poly (glycerol-sebacate) for contact guidance applications. Biomaterials, 2006. 27(12): p. 2558-2565.
138. Fidkowski, C., et al., Endothelialized microvasculature based on a biodegradable elastomer. Tissue Engineering, 2005. 11 (1-2): p. 302-309.
139. Bettinger, C. J., et al., Silk Fibroin Microfluidic Devices. Advanced Materials (Deerfield Beach, Fla.), 2007. 19(5): p. 2847-2850.
140. Altman, G. H., et al., Silk-based biomaterials. Biomaterials, 2003. 24(3): p. 401-416.
141. Therriault, D., S. R. White, and J. A. Lewis, Chaotic mixing in three-dimensional microvascular networks fabricated by direct-write assembly. Nature Materials, 2003. 2(4): p. 265-271.
142. Nahmias, Y., et al., Laser-guided direct writing for three-dimensional tissue engineering. Biotechnology and Bioengineering, 2005. 92(2): p. 129-136.
143. Cho, H., et al., How the capillary burst microvalve works. Journal of Colloid and Interface Science, 2007. 306(2): p. 379-385.
144. Choi, C. H., et al., Generation of monodisperse alginate microbeads and in situ encapsulation of cell in microfluidic device. Biomedical Microdevices, 2007. 9(6): p. 855-862.
145. Golden, A. P. and J. Tien, Fabrication of microfluidic hydrogels using molded gelatin as a sacrificial element. Lab on a Chip, 2007. 7(6): p. 720-725.
146. Park, T. G. and A. S. Hoffman, Synthesis and characterization of pH-and or temperaturesensitive hydrogels. Journal of Applied Polymer Science, 1992. 46(4): p. 659-671.
147. Sun, G. M., X. Z. Zhang, and C. C. Chu, Formulation and characterization of chitosan-based hydrogel films having both temperature and pH sensitivity. Journal of Materials Science. Materials in Medicine, 2007. 18(8): p. 1563-1577.
148. Klumb, L. A. and T. A. Horbett, Design of insulin delivery devices based on glucose sensitive membranes. Journal of Controlled Release, 1992. 18(1): p. 59-80.
149. Khetan, S., C. Chung, and J. A. Burdick, Tuning hydrogel properties for applications in tissue engineering. Conference Proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference, 2009. 1: p. 2094-2096.
150. Chung, S. and D. J. Andrew, The formation of epithelial tubes. Journal of Cell Science, 2008. 121(21): p. 3501-3504.
151. Lubarsky, B. and M. A. Krasnow, Tube morphogenesis: making and shaping biological tubes. Cell, 2003. 112(1): p. 19-28.
152. Lutolf, M. P., Biomaterials: spotlight on hydrogels. Nature Materials, 2009. 8(6): p. 451-453.
153. Kloxin, A. M., et al., Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science, 2009. 324(5923): p. 59-63.